The fundamental mechanisms that mediate pathologic vascular and perivascular cellular proliferation in the kidney are not yet well defined. Such proliferation may cause vascular insufficiency through the lumenal narrowing seen in hypertensive nephrosclerosis, or it may result in the architectural disruption of functioning tissue units as in proliferative glomerulopathies. The goal of these studies is to identify the role of the vascular endothelial cell in producing mediators of vascular and perivascular proliferation. Cultured endothelial cells produce several well-characterized growth factors, including platelet-derived growth factor (PDGF) and interleukin 1 (IL-1), both of which affect the growth properties of cells that participate in pathologic subendothelial proliferation. The proposed work will address the in vitro and in vivo factors that influence endothelial expression of these growth factors and transforming growth factor beta (TGF-beta). We have recently shown the expression of PDGF activity by cultured human renal microvascular endothelial cells to be regulated by exposure of cells to thrombin and transforming growth factor beta (TGF-beta). We will quantify endothelial levels of specific growth factor messenger RNA and release of growth factor activity into conditioned medium as indices of in vitro growth factor expression under varying culture conditions and exposure to biochemical agonists relevant at sites of vascular proliferation. In vivo studies will use in situ hybridization methods to quantify growth factor mRNA expression levels in specific cell types (endothelium) within kidney specimens from patients with renal diseases marked by vascular and perivascular proliferation. Thus by combining in vitro and in vivo approaches, these studies should provide better understanding of the factors influencing renal endothelial growth factor expression and the role that local tissue growth factor production plays in renal vascular and perivascular proliferative diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK038517-02
Application #
3237904
Study Section
Pathology A Study Section (PTHA)
Project Start
1987-04-01
Project End
1990-03-31
Budget Start
1988-04-01
Budget End
1989-03-31
Support Year
2
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37203
Takahashi, Keiko; Kim, Rachel; Lauhan, Colette et al. (2017) Expression of receptor-type protein tyrosine phosphatase in developing and adult renal vasculature. PLoS One 12:e0177192
Takahashi, Keiko; Matafonov, Anton; Sumarriva, Katherine et al. (2014) CD148 tyrosine phosphatase promotes cadherin cell adhesion. PLoS One 9:e112753
Takahashi, Keiko; Mernaugh, Raymond L; Friedman, David B et al. (2012) Thrombospondin-1 acts as a ligand for CD148 tyrosine phosphatase. Proc Natl Acad Sci U S A 109:1985-90
Qu, Xianghu; Tompkins, Kevin; Batts, Lorene E et al. (2010) Abnormal embryonic lymphatic vessel development in Tie1 hypomorphic mice. Development 137:1285-95
Tsuboi, Nobuo; Utsunomiya, Tadahiko; Roberts, Richard L et al. (2008) The tyrosine phosphatase CD148 interacts with the p85 regulatory subunit of phosphoinositide 3-kinase. Biochem J 413:193-200
Takahashi, Takamune; Takahashi, Keiko; Mernaugh, Raymond L et al. (2006) A monoclonal antibody against CD148, a receptor-like tyrosine phosphatase, inhibits endothelial-cell growth and angiogenesis. Blood 108:1234-42
Takahashi, Takamune; Takahashi, Keiko; St John, Patricia L et al. (2003) A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development. Mol Cell Biol 23:1817-31
Du, Jianguo; Luan, Jing; Liu, Hua et al. (2002) Potential role for Duffy antigen chemokine-binding protein in angiogenesis and maintenance of homeostasis in response to stress. J Leukoc Biol 71:141-53
Daniel, T O; Abrahamson, D (2000) Endothelial signal integration in vascular assembly. Annu Rev Physiol 62:649-71
Addison, C L; Daniel, T O; Burdick, M D et al. (2000) The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity. J Immunol 165:5269-77

Showing the most recent 10 out of 30 publications